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Sensing of HSV-1 by the cGAS–STING pathway in
microglia orchestrates antiviral defence in the CNS
Line S. Reinert1,2, Katarı´na Lopusˇna´1,3, Henriette Winther1,2, Chenglong Sun1,2, Martin K. Thomsen1,2,
Ramya Nandakumar1,2, Trine H. Mogensen1,2,4, Morten Meyer5, Christian Vægter1, Jens R. Nyengaard6,
Katherine A. Fitzgerald7 & Søren R. Paludan1,2
Herpes simplex encephalitis (HSE) is the most common form of acute viral encephalitis in
industrialized countries. Type I interferon (IFN) is important for control of herpes simplex
virus (HSV-1) in the central nervous system (CNS). Here we show that microglia are the main
source of HSV-induced type I IFN expression in CNS cells and these cytokines are induced in
a cGAS–STING-dependent manner. Consistently, mice defective in cGAS or STING are
highly susceptible to acute HSE. Although STING is redundant for cell-autonomous antiviral
resistance in astrocytes and neurons, viral replication is strongly increased in neurons in
STING-deﬁcient mice. Interestingly, HSV-infected microglia confer STING-dependent antiviral
activities in neurons and prime type I IFN production in astrocytes through the TLR3 pathway.
Thus, sensing of HSV-1 infection in the CNS by microglia through the cGAS–STING pathway
orchestrates an antiviral program that includes type I IFNs and immune-priming of other
cell types.
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V
iral infections in the central nervous system (CNS) can
result in devastating diseases such as encephalitis, which
can cause irreversible damage to the CNS and fatality1.
Herpes simplex virus (HSV) type 1 is a neurotropic virus and
is a major cause of CNS infections, including herpes simplex
encephalitis (HSE)1. The innate immune response to infection is
essential for host control of HSV2. The innate immune system
utilizes pattern recognition receptors (PRRs) to detect microbial
molecules and stimulate host defense, in which type I interferon
(IFN) have a particularly important role in viral infection3.
Viruses induce type I IFN expression mainly through nucleic
acids and (RNA-/DNA-sensing) PRRs, as well as downstream
type I IFN-inducing signalling pathways, which are well
described4,5.
Genetic studies in humans have led to the identiﬁcation
of defects in the RNA-sensing TLR3 pathway in patients with
HSE6–10, and this ﬁnding has been conﬁrmed in a mouse
model for HSV-2 myelitis, in which astrocytes sense the virus in a
TLR3-dependent manner11. However, another study using
induced pluripotent stem cells derived from patient dermal
ﬁbroblasts suggested that neurons and oligodendrocytes control
HSV-1 replication in a TLR3-dependent manner in vitro12. Thus,
the cell-type-speciﬁc action of the TLR3 pathway is context
dependent and it remains unresolved whether a priming step is
needed and also whether TLR3 acts in concert with other innate
pathways to exert antiviral activity in the CNS.
HSV-1 carries its genetic information in the form of
double-stranded DNA (dsDNA), and advances in the basic
understanding of innate immune sensing have revealed that
cytosolic dsDNA is a potent inducer of innate immune
responses13. Several DNA sensors have been identiﬁed,
including cyclic GMP–AMP synthase (cGAS)14, and all type I
IFN-inducing cytoplasmic DNA sensors signal through the
adaptor protein stimulator of type I IFN genes (STING)13. We
reported that HSV-1 entry into macrophages leads to abundant
accumulation of viral DNA in the cytoplasm, which is where the
DNA is sensed to induce type I IFN expression15. Microglia are
resident macrophages of the CNS and have important roles in
both protective and pathological immune responses in the CNS16.
Microglia express a wide panel of PRRs and are importance for
defense against HSV-1 (ref. 17). Despite the well-documented
role for DNA sensing in recognition of several pathogens,
published data on the mechanisms of action of this pathway
in vivo are limited. For instance, it is unknown which cell types
utilize the STING-dependent DNA-sensing pathway to recognize
HSV-1 in vivo and how this may inﬂuence the intercellular
communication network in the tissue.
In this work, we demonstrate that microglia are the main
producers of type I IFN after HSV-1 infection and this cytokine
production is STING dependent. cGAS deﬁciency and STING
deﬁciency renders mice susceptible to HSE after peripheral
infection in the eye, and correlates with impaired type I IFN
expression in the CNS. In vitro infection of neurons and glia cells
reveals that microglia, but not neurons or astrocytes, exhibit
increased viral replication in the absence of STING. By contrast,
in vivo STING deﬁciency increases HSV-1 replication in
microglia. Interestingly, HSV-1-infected microglia transfer
antiviral activity to neurons in a STING-dependent manner. In
addition, treatment of astrocytes with type I IFN or supernatants
from infected wild type (WT), but not STING deﬁcient, microglia
induces TLR3 expression by astrocytes, thus enabling a response
through these pathways. Collectively, these data suggest that
innate sensing of HSV-1 DNA in the brain by microglia induces a
paracrine antiviral type I IFN response and also enables innate
sensing pathways in other cell types, including the TLR3 pathway
known to be essential for protection against HSE in humans.
Results
Mice deﬁcient in cGAS or STING are susceptible to HSE. To
mimic the natural route of HSV-1 entry into the CNS through
retrograde transport we used a model for ocular HSV-1 infection.
For this study, we used cGAS / and Goldenticket (gt) mice,
which harbour a single nucleotide variant (T596A) of STING that
functions as a null allele18. By western blotting, we demonstrated
the lack of STING expression in the Gt mice, including in the
CNS (Supplementary Fig. 1). When WT, cGAS / and Stinggt/gt
mice were challenged with HSV-1 (strains Mckrae or KOS), we
observed severe disease development in mice with a defective
cGAS–STING pathway, as shown by disease scores reﬂecting
infection in both the eye (Fig. 1a; Supplementary Fig. 2a,c) and in
the CNS (Fig. 1b,c, Supplementary Fig. 2d). The mice
lacking STING also lost weight rapidly after infection with the
Mckrae strain (Supplementary Fig. 2e), and succumbed to
infection on day 6 post infection whereas the WT mice
survived through the 8 days of the experiment (Fig. 1d).
Previous reports have demonstrated elevated HSV-1 load in the
cornea of STING-deﬁcient mice after HSV-1 infection19,20. When
examining viral titres at different locations from the site of
inoculation to the CNS (Fig. 1e), we were able to detect HSV-1
(Mckrae) in all compartments and consistently found higher viral
load in samples from the cGAS- and STING-deﬁcient mice
(Fig. 1f–i). Further analysis of the early events in HSV-1
replication in neuronal tissue showed that the levels of HSV-1
in trigeminal ganglia was comparable between WT and
STINGgt/gt mice at day 2 post infection, after which we
observed signiﬁcantly elevated viral load in trigeminal ganglia
from STING-deﬁcient mice (Supplementary Fig. 2f). While HSV-
1 was detectable in the brain stem from day 3 after infection in
WT mice, the virus reached the brain stem already on day 2 in
STING-deﬁcient mice, and was detected in higher levels than in
WT mice from the time of entry into the brain (Supplementary
Fig. 2g). Infection with the HSV-1 KOS strain also led to elevated
viral load in the brain stem in the STING-deﬁcient mice, but
this strain was unable to spread further in the brains of STING-
deﬁcient mice, similar to the WT mice (Supplementary Fig. 2h,i).
To evaluate whether a defective cGAS–STING pathway affects
the path of HSV-1 neuro-entry and the pattern of viral spread
within the CNS, we sliced whole mouse brains from infected
mice into 60 mm sections and stained every sixth section with
anti-HSV-1 antibodies. Areas positive for HSV-1 were observed
in the medulla of brains from both WT and STING-deﬁcient
mice, although we observed a larger number of HSV-1-infected
cells in the sections from the STING-deﬁcient mice (Fig. 1j–l).
These data are consistent with HSV-1 entering into the CNS
through the neuronal route via the trigeminal nerve. When
looking beyond the medulla, we found HSV-1-positive areas only
in the pons in WT mice (Fig. 1k; Supplementary Fig. 3). By
contrast, in the brains from STING-deﬁcient mice, the virus was
not restricted to the area around the medulla, but was widely
disseminated to the midbrain, hypothalamus, and the preoptic
area (Supplementary Fig. 3).
Since we observed higher viral load in cGAS- and STING-
deﬁcient mice already in the eye, and also observed accelerated
viral entry in the brain tissue, it remained possible that the
elevated viral load in the CNS was due to a requirement of
the cGAS–STING pathway in the periphery and not within the
brain. Therefore, we isolated and cultured brain slices from
newborn WT and STING-deﬁcient mice, and infected with
HSV-1 (Fig. 1m–o). The homogenized slices, as well as
supernatants isolated from cultures of STING-deﬁcient brains
contained signiﬁcantly more virus than that of WT brain slices,
thus suggesting that the brain per se relies on STING to mount a
defense against HSV-1 infection.
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Elevated viral load in STING-deﬁcient microglia and neurons.
To examine the role for STING in cell-autonomous control of
HSV-1 replication, we isolated neuronal cells from newborn mice
and differentiated cells in vitro into neurons, astrocytes and
microglia. The purity of the speciﬁc cell types was evaluated to be
in the range 89–97% depending on the cell type (Supplementary
Fig. 4). Consistent with the literature on HSV-1 replication in
human, in induced pluripotent stem cell-derived neuronal cells12,
HSV-1 replicated very well in WT neurons and astrocytes, but
only weakly in microglia (Fig. 2a–c). In neurons and astrocytes,
STING deﬁciency did not lead to elevated viral growth. In
microglia, STING deﬁciency was associated with the elevated
virus yield (Fig. 2c), although the levels of virus were 3–4 logs
lower than in neurons and astrocytes. These data suggest that
STING is involved in control of HSV-1 replication in microglia,
whereas astrocytes and neurons utilize antiviral mechanisms
independent of STING in vitro.
To examine which cell types harboured viral antigens in
the CNS of WT and STING-deﬁcient mice, tissue sections
from brain stems were stained with antibodies against HSV-1 and
cell-type-speciﬁc markers. As expected, we observed a larger
proportion of HSV-1-positive cells in the STING-deﬁcient mice
as compared with WT mice (Fig. 2d–g). The staining for HSV-1
antigens exhibited a preferential nuclear pattern consistent with
HSV-1 replication occurring in the nucleus (Fig. 2d). However,
we did not observe a higher number of astrocytes containing viral
antigen in the brains from STING-deﬁcient mice as compared
with WT mice (Fig. 2d,e), consistent with the ﬁndings in vitro
(Fig. 2a). By contrast, when examining viral antigens in
neurons in situ, we observed many more infected Neuronal
Nuclei (NeuN)-positive cells in STING-deﬁcient versus WT
mice (Fig. 2f). Quantiﬁcation of the immunohistochemistry
data showed that 12.4±2.6% of S100þ WT cells (astrocytes)
were HSV-1þ , while 14.9±3.2% of the STING-deﬁcient
astrocytes were HSV-1þ . For the neurons, 9.9±7.7% of WT
NeuNþ cells were positive for HSV-1, while 33.7±1.5% of the
STING-deﬁcient NeuNþ cells were HSV-1þ . With respect to
microglia, the data showed a pronounced elevation in the level of
viral antigen in cells from STING-deﬁcient mice as compared
with WT mice (Fig. 2g). However, the viral antigen in microglia
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Figure 1 | Mice deﬁcient in cGAS or STING are susceptible to HSE and exhibit impaired antiviral responses. Mice were infected in the cornea with
1 106 PFU per eye of HSV-1 (strain Mckrae). On subsequent days, animals were scored for (a) eye swelling, (b) hydrocephalus, and (c) symptoms related to
neurological disease and (d) survival. (e) Route of virus spread from the eye to the CNS. (f–i) Eye washes, trigeminal ganglia, brain stem and brains were
isolated on the indicated time points post infection, and viral load was quantiﬁed using plaque assay. n¼ 9 mice per group (a–i). (j) Tissue section from the
brain stem of WT and Stinggt/gt mice infected for 6 days with HSV-1 were stained with anti-HSV-1. n¼ 5-6 mice per group. The original magniﬁcations are
2.5 and 20 for the zoomed in images. (k–l) The number of HSV-1-positive cells in six tissue sections from the medulla and pons were quantiﬁed, and
presented as means± s.e.m. n¼ 3–9 per group. (m–o) Organotypic brain slices from WTand Stinggt/gt mice were cultured and infected with 5 103 PFU of
HSV-1. The viral load in (n) the culture medium on day 2 and (o) in homogenized brain slices on 6 days post infection was determined by plaque assay. Data
are shown as mean values± s.e.m., n¼6–8 wells with three brain slices in each. Symbols for P-values used in the ﬁgures: *0.01oPo0.05; **0.001oPo0.01;
***Po0.001; NS, not signiﬁcant. Red and green asterisks indicate P-values between WT and relevant KO mice at speciﬁc days post infection.
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quantiﬁed by plaque assay. Data are presented as means± s.e.m. *0.01oPo0.05; NS, not signiﬁcant, n¼ 5–8 per group. (d–g) Tissue sections from the
brain stem of six WTand 6 Stinggt/gt mice isolated 6 days after infection with HSV-1 (1 106 PFU per eye) were stained with an antibody against HSV-1 and
antibodies against cell-type-speciﬁc markers: (d) S100, a nuclear astrocyte marker; (e) GFAP, a ﬁbrillary astrocyte marker; (f) NeuN, neurons; and (g) Iba1,
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mainly localized to the cytoplasm and not the nucleus, suggesting
uptake of viral antigen rather than the productive replication.
These data are consistent with the in vitro data showing only
modest HSV-1 replication in microglia cells, although this was
signiﬁcantly elevated in the absence of STING (Fig. 2c).
Altogether, the elevated viral load in STING-deﬁcient neurons
in vivo but not in vitro suggests the existence of a STING-
dependent intercellular network, which transfers antiviral signals
to neurons in vivo.
STING-dependent type I IFN production by microglia. The
data presented above suggest that microglia rely on STING to
activate antiviral defense, and also that there is STING-dependent
transfer of antiviral signals through the tissue in the CNS. Type I
IFNs are pivotal for control of HSV-1 replication in the CNS, and
we therefore wanted to evaluate the expression and function of
this class of cytokines in the brain during HSV-1 infection. In
brain stem homogenates from infected mice, signiﬁcantly reduced
induction of IFN-b gene expression was observed after HSV-1
infection in mice lacking STING (Fig. 3a). This led to the reduced
expression of the IFN-stimulated gene (ISG) viperin in the
infected tissue in STING-deﬁcient mice (Fig. 3b). Although
viperin has been shown not to have antiviral activity against WT
HSV-1 in vitro21, we used it as a marker of ISG expression.
To identify which cells of the CNS produced type I IFN, we
isolated supernatants from neurons, astrocytes and microglia
infected with HSV-1 and measured type I IFN bioactivity. While
neurons failed to induce type I IFN in response to HSV-1
infection, astrocytes mounted a clear but modest IFN-a/b
production (Fig. 3c). In contrast to this, microglia mounted
response to HSV-1 infection with production of high levels of
ca
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type I IFN, and this was entirely dependent on STING and cGAS
(Fig. 3c,d). Similar data were obtained when we examined IFN-b
expression at the messenger RNA (mRNA) levels in the three cell
types with both McKrae strain and with the KOS strain (Fig. 3e).
Given the ﬁnding that microglia responded to HSV-1 infection
with the most potent type I IFN response in a STING-dependent
manner, we wanted to evaluate whether the cGAS–STING
pathway was more active in this cell type than in astrocytes
and neurons. To test this, we ﬁrst determined the expression
levels of cGAS and STING in neurons, astrocytes, and microglia,
and observed that the ability of the cell types tested to produce
type I IFN correlated with the expression of cGAS and
STING (Fig. 3f,g). In line with this, and mirroring what was
observed after HSV-1 infection, the relative stimulation of
type I IFN production by synthetic DNA in the three cell types
was neuronsoastrocytesomicroglia (Supplementary Fig. 5). On
DNA stimulation, STING translocates to vesicular structures22,
and accumulation of perinuclear STING foci is often used as a
measure of activation of the STING pathway. To further examine
whether the cGAS–STING pathway is activated more potently in
microglia than astrocytes, we mixed these two cell types, infected
with HSV-1, and used formation of STING foci as readout. In line
with the stronger expression of type I IFNs by microglia cells, we
observed formation of STING foci in a signiﬁcantly higher
proportion of the microglia (glial ﬁbrillary acidic protein
(GFAP) ) as compared with the astrocytes (GFAPþ ; Fig. 3h,i).
HSV-1 can enter most cell types, but only replicates efﬁciently
in a subset of cells. The data shown in Fig. 2a,c demonstrate that
among the identiﬁed type I IFN-producing cells, HSV-1 replicates
efﬁciently in neurons and astrocytes but less so in microglia.
Productive viral replication may impair various cellular functions,
including production and responsiveness to type I IFN.
Therefore, we wanted to evaluate whether the establishment of
productive replication affected the ability of the different cell
types to express IFN-b. For this purpose, we infected cells with a
high multiplicity of infection (MOI) of HSV-1 virus expressing
enhanced green ﬂuorescent protein (eGFP) under the control of a
constitutive promoter, and sorted GFPþ and GFP cells for
further analysis. As shown in Supplementary Fig. 6a, expression
of GFP correlated with the expression of the late viral protein gB,
thus validating that GFP expression was a reasonable measure for
productive HSV-1 replication. For the astrocytes, we found that
GFP cells were stimulated to express IFN-b, whereas the
productively infected astrocytes were unable to produce IFN-b
(Fig. 3j). By contrast, microglia produced IFN-b in response to
HSV-1 infection irrespective of whether the virus had established
productive infection or not (Fig. 3j). When examining expression
of ISGs, we found that astrocytes produced this class of genes
even when productively infected (Fig. 3k; Supplementary
Fig. 6b,c). This was seen over a range of infectious doses
(Fig. 3j,k; Supplementary Fig. 6d,e). This suggests that although
the productive viral replication impaires production of IFN-b in
astrocytes, the ability to respond to type I IFNs is retained.
Thus, microglia are the main source of type I IFN, during
HSV-1 infection of CNS cells and evokes this response in a
STING-dependent manner, which is not affected by the
establishment of productive infection by the virus.
STING-independent recruitment of microglia to infection foci.
Next, we were interested in evaluating the STING-dependent
nature of the accumulation of microglia and expression of type I
IFN-stimulated genes in the foci of infection in the brain.
Therefore, we ﬁrst isolated RNA from the brain stems of WT and
STING-deﬁcient mice infected for 6 days. As seen in Fig. 4a, brain
stems of infected mice had higher levels of a microglia marker
(Iba1) mRNA than uninfected mice, and this was independent of
the genotype of the mice, despite signiﬁcantly higher levels
of viral transcripts in the brain stem of the STING-deﬁcient mice
(Fig. 4b,c). Since the elevation of Iba1 mRNA levels could be
caused by either induction of the gene or recruitment or division
of Iba1-expressing cells, we also isolated single cells from brain
stems of infected WT and STING-deﬁcient mice to perform ﬂow
cytometric analysis for Iba1. This revealed comparable results
from the two sets of mice, both in terms of cell counts and
intensity of the ﬂuorescent signal (Fig. 4d). Since Iba1 can
be expressed by cell types other than microglia, such as bone-
marrow-derived macrophages, we determined the cell
population expressing CD11bþCD45lo-Medium to deﬁne micro-
glia. This analysis showed comparable number of CD11bþ
CD45lo-Medium in the brain stem of HSV-1-infected WT and
STING-deﬁcient mice (Fig. 4e; Supplementary Fig. 7a,b). More-
over, these data demonstrate thato2% of the gated single cells in
the infected brain stem are CD11bþCD45high as compared with
415% being CD11bþCD45lo-Medium (Supplementary Fig. 7b,c).
This suggests that microglia, rather than recruited macrophages,
are accumulating in infected areas at the time point examined.
Finally, we stained brain stem tissue sections from untreated
and HSV-1-infected mice with anti-Iba1 and analysed
microscopically. Using this approach, we easily observed micro-
glia in the infected areas with no noticeable difference between
the genotypes (Fig. 4g). Thus, accumulation of microglia in areas
of HSV-1 infection in the brain occurs in a manner independent
of STING.
Next, we wanted to examine the role of the STING pathway in
mediating the type I IFN response in cell types other than
microglia in and around the infected area in the CNS. Tissue
sections from the brain stem of uninfected and HSV-1-infected
WT and STING-deﬁcient mice were stained with anti-viperin,
anti-HSV-1 and anti-Iba1 antibodies and analysed by confocal
microscopy. First, we noted that viperinþ staining, consistent
with the data shown in Fig. 3b found in many WT cells was
largely absent in HSV-1þ cells, suggesting that type I IFN
stimulation did prevent the efﬁcient viral replication in the brain
(Fig. 5a). Second, we found viperin-positive staining in both
Iba1þ and Iba1 cells in WT mice, thus suggesting stimulation
of type I IFN responses also in non-microglial cells. Interestingly,
in sections from STING-deﬁcient mice, the modest positive
staining for viperin was seen preferentially in microglia with
92±3% of viperinþ cells also being Iba1þ . These data
suggest that STING is essential to evoke expression of ISGs in
non-microglial cells in the CNS.
To start elucidating how IFNs may functionally modulate
non-microglial cells, astrocytes and neurons were treated with
IFN-a/b, followed by infection with HSV-1. Subsequently, we
evaluated the ability of these cell types to control infection and
induce IFN-b gene expression. Type I IFN treatment led to
signiﬁcantly lower virus replication in both cell types, indepen-
dent of the genotype of the infected cell (Fig. 5b–d). Moreover,
although type I IFN treatment did not enable neurons to express
IFN-b on HSV-1 infection, this treatment primed astrocytes to
become high IFN-b producers in response to HSV-1 infection
(Fig. 5e,f). Thus, paracrine stimulation of neurons and astrocytes
with type I IFN evokes antiviral activity in both cell types and
primes virus-induced IFN-b expression in astrocytes.
Microglia induce STING-dependent antiviral programs.
Finally, we were interested in determining whether microglia
were able to deliver signals to other cell types in the CNS and
to evaluate the role of STING in these events. To do this, we
used a model where conditioned medium from microglia were
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transferred to cultures of neurons or astrocytes, and functional
analyses were performed in these cells (Fig. 6a,h). First, we col-
lected media from WT and STING-deﬁcient microglia challenged
with HSV-1 or synthetic DNA and added to neuron cultures. For
comparison, we also treated neurons directly with IFN-a/b. As
expected, type I IFN and supernatants from dsDNA-treated
microglia signiﬁcantly impaired HSV-1 replication in neurons
(Fig. 6b). Importantly, supernatants from HSV-1-infected WT
microglia reduced viral replication to the same extent as stimu-
lation with recombinant type I IFN, whereas STING-deﬁcient
microglia failed to transfer antiviral activity to neurons (Fig. 6b).
Although the neurons did not produce type I IFN (Fig. 3c,d), they
did respond to type I IFN treatment with a classical ISG
expression proﬁle irrespetive of their STING genotype (Fig. 6c–g;
Supplementary Fig. 8), and this response was also evoked by
supernatants from HSV-1-infected WT microglia (Fig. 6g).
Supernatants from HSV-1-infected microglia also evoked anti-
HSV-1 activity in astrocytes, but unlike what was observed in the
neurons, this occured in a manner independent of STING
(Fig. 6i). Interestingly, the STING-independent nature of the
antiviral signals delivered from HSV-infected microglia to
astrocytes is in line with the ﬁndings in vivo, where viral infection
in astrocytes was not affected by STING deﬁciency (Fig. 2d,e).
To describe how microglia may employ the cGAS–STING
pathway to prime type I IFN production in astrocytes, we ﬁrst
isolated supernatants from microglia stimulated with synthetic
dsDNA, and added the conditioned media to astrocytes, which
were subsequently stimulated with the dsRNA analogue poly(I:C).
We found that media from DNA-treated microglia signiﬁcantly
potentiated IFNb stimulation by poly(I:C) (Fig. 6j). Addition of
poly(I:C) directly to the medium stimulated TLR3-dependent type
I IFN responses in astrocytes (Supplementary Fig. 9), and we
previously reported that this cell type relies on TLR3 to sense
HSV-2 infection11. Therefore, we examined if HSV-1-induced
expression of IFNb and the ISG CXCL10 was affected by TLR3
deﬁciency. As seen in Fig. 6k,l, TLR3 was essential for full
HSV-1-induced expression of IFNb and CXCL10 by both resting
and type I IFN-primed astrocytes. Finally, we examined whether
the activation of the cGAS–STING pathway in microglia could
transfer priming signals to astrocytes. Importantly, astrocytes
cultured with conditioned medium from dsDNA-stimulated WT
but not STING-deﬁcient microglia responded to HSV-1 infection
with strong induction of IFNb mRNA expression (Fig. 6m). The
priming of virus-induced IFNb expression in astrocytes by
microglia activated through the cGAS–STING pathway
correlated with the expression of TLR3, which was induced by
type I IFN treatment and medium from HSV-1-infected or
dsDNA-stimulated WT microglia (Fig. 6n). Together with the data
presented in Fig. 3c, these data demonstrate that resting astrocytes
rely on the STING pathway to produce type I IFN in response to
HSV-1 infection, and that microglia on DNA sensing can prime
the TLR3 pathway in astrocytes to enable this cell type to respond
to HSV-1 infection with high expression of type I IFNs.
Collectively, the data demonstrate that HSV-1-infected micro-
glia transfer STING-dependent signals to adjacent cells, leading to
the antiviral activity in neurons and priming of the TLR3 pathway
in astrocytes.
Discussion
A large proportion of the human population is infected with
HSV-1, but only a small minority experience HSE23. In recent
years, it has emerged that the innate immune system, including the
TLR3-type I IFN axis is important for protection against HSV-1
infection in the CNS and prevention of HSE6–10. In this work, we
demonstrate that a defective cGAS–STING pathway renders mice
highly susceptible to HSE-related disease after infection at an
epithelial surface in the periphery. Moreover, we show that among
CNS cells, particularly microglia utilize the cGAS–STING pathway
to orchestrate the antiviral response through at least two
mechanisms acting in a paracrine manner: antiviral action of
type I IFN, and priming of innate immune sensing pathways,
including the TLR3 pathway (Supplementary Fig. 10).
Previous studies in murine models have suggested that TLR2
deﬁciency protects against the pathological inﬂammatory
response in the brain after intracranial HSV-1 infection24,
whereas lack of TLR9 did not have an impact on the viral
replication in the brain after ocular or intracranial infection25,26.
Moreover, TIR-domain-containing adapter-inducing interferon-b
(TRIF)-deﬁcient mice exhibited markedly increased susceptibility
to HSE-related disease and impaired viral control in the brain
after intranasal HSV-1 infection, whereas mitochondrial
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antiviral-signaling protein (MAVS)-deﬁcient mice had a modest
but signiﬁcant phenotype in the same model27. It has been
reported that cGAS and STING-deﬁcient mice exhibit impaired
defense against HSV-1 in the CNS after infection through the
intravenous route22,28. In this model, the entry of the virus into
the CNS is not well understood, and includes the hematogenous
route29. By contrast, the natural route of entry for HSV-1 into the
CNS is via sensory neurons. Thus, together with the previous
report on HSV-1 infection in the CNS after intranasal infection of
TRIF-deﬁcient mice27, and the extensive literature on defects in
the TLR3 pathways in HSE patients6–10, the present study
corroborates the cGAS–STING and the TLR3–TRIF pathways as
the main innate sensing pathways conferring control of HSV-1
infection in the CNS. Although we observed very similar
phenotypes for cGAS- and STING-deﬁcient mice, it should be
mentioned that we cannot formally exclude that STING also has
cGAS-independent functions in defense against HSV-1 in the
CNS30,31.
Parallel to our work, David Leib and colleagues studied HSV-1
infection in STING-deﬁcient mice20. While Parker et al. used the
KOS and 17 strains for their ocular infection experiments, we
mainly used the McKrae strain, since it is more neuro-invasive.
Some of our results with the McKrae strain were repeated with
the KOS strain. We found that more STING-deﬁcient than WT
mice succumbed after ocular infection with the McKrae strain,
and Parker et al. found the same for the 17 strain20. Both studies
show increased viral load in the eyes and trigeminal ganglia of
STING-deﬁcient mice after ocular infection with the KOS strain,
and also that the KOS strain does not replicate to high titres in
the brain even in the absence of STING20. To overcome this,
Parker et al. injected virus directly into the brain and found lower
levels of IFNb in the brains of infected Sting / mice, in
agreement with our data. However, interestingly, expression
of inﬂammatory cytokines was elevated in corneas of
STING-deﬁcient mice20. This may be induced by other PRRs
such as TLRs, which have been reported to be involved in sensing
of HSV-1 in the cornea32. Therefore, these two studies together
establish an essential role of STING in control of HSV-1 after
corneal infection, and our choice of the McKrae strain has
allowed us focus more on the infection in the CNS.
A central ﬁnding of the present study is that microglia
represent the main source of type I IFN during HSV-1 infection
and utilizes the cGAS–STING pathway to induce this response.
Moreover, the cGAS–STING pathway is important for cell-
autonomous control of the viral replication in microglia but not
in astrocytes and neurons. This indicates that in the CNS, the
cGAS–STING pathway is important mainly for the antiviral
action of microglia, which in turn disseminate antiviral activities
to other cell types of the CNS. The importance of microglia in
HSV-1-induced type I IFN production is consistent with work by
others17. In this work, we identiﬁed two mechanisms
through which HSV-infected microglia can transfer antiviral
activities to other cell types in a STING-dependent manner. First,
microglia-derived type I IFN leads to signiﬁcant inhibition of
HSV-1 replication in the highly permissive neurons. The ability of
type I IFN to inhibit HSV replication in neurons is in agreement
with earlier work by us and others11,33,34. Previous work has
demonstrated lower steady state and type I IFN-induced levels of
several ISGs associated with cell death in neurons as compared
with mitotic cells33. Future work should resolve whether type I
IFN activates a specialized antiviral program in neurons. Second,
we found that type I IFN and supernatants from HSV-infected
microglia upregulated TLR3 expression in astrocytes, and this cell
type accordingly did acquire elevated responsiveness through the
respective pathways. Given the well-described role of the
TLR3–TRIF pathway in control of HSV-1 in the CNS in
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humans and mice6,7,27, these data suggest that a defective cGAS–
STING pathway also indirectly hampers the ability to evoke full
antiviral activity through the TLR3–TRIF pathway. The concept
of cross-talk between the type I IFN-inducing pathways in the
CNS during HSV-1 infection is further supported by the previous
ﬁnding that TRIF-deﬁcient mice, along with higher viral load,
have signiﬁcantly elevated IFN-b expression in the brain27. On
the basis of the data in the present work, we suggest that the
elevated type I IFN-b expression in TRIF-deﬁcient mice is
stimulated through the cGAS–STING pathway. It is tempting to
speculate that the detection of HSV-1 through multiple type I
IFN-inducing pathways that interact in a manner involving
multiple cell types enables the organism to achieve optimal
antiviral activity, with the lowest possible amounts of type I IFN.
Such a scenario would render the host antiviral response less
sensitive to viral evasion and targeting of speciﬁc cell types or
antiviral pathways.
Collectively, this work demonstrates that the STING-
dependent DNA-sensing system represents a key pathway to
control HSV-1 replication in the CNS, and that this is highly
dependent on viral DNA recognition in microglia. Thus, by
possession of strong responsiveness through the cGAS–STING
pathway, microglia act upstream in an intercellular network in
the CNS during HSV-1 infection. Through this network,
microglia disseminate antiviral activities through the tissue and
also primes select innate pathways in other cell types in the CNS,
which together orchestrate the antiviral response.
Methods
Mice. C57BL/6, STINGgt/gt and cGAS / mice were bred at Taconic M&B.
Isoﬂourane (Abbott), or (Ketamine (MSD Animal Health) and Xylazin
(RompunVet)) was used to anaesthetize mice. All described animal experiments
have been reviewed and approved by Danish government authorities and hence
comply with Danish laws (The Animal Experiments Inspectorate, Slotsholmsgade
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10, 1216 København K, Denmark). All efforts were made to minimize suffering and
mice were monitored daily during infection. The mice were not randomized but
after HSV infection, the information about mice strain and treatment were blinded
to the investigators. No animals were excluded from the analysis.
Viruses and reagents. Dulbecco’s Modiﬁed Eagle Medium (DME`M) was
obtained from BioWhittaker and supplemented with 100 IUml 1 penicillin,
100mgml 1 streptomycin and LPS-free FCS (BioWhittaker). IFN-b/a (PBL), and
ProLong Gold, DAPI, TRIzol, Poly I:C (all from Invitrogen) Lipofectamine 2000
(Invitrogen) were used in the experiments described below. HSV-1 (strains KOS
and McKrae) was grown in Vero cells. The Vero cells used were from the lab stock.
The titres of the stocks used were 8–14 109 PFUml 1. Titres were determined by
plaque assay on Vero cells. Beriglobin was used to neutralize extracellular HSV-1
(CSL Behring) and fully neutralized the virus in the dilutions used to calculate
titres. Both strains were used for infection of mice, while only KOS strain was used
for in vitro stimulation. GFP-HSV-1 (HSV-1-expressing eGFP driven by the CMV
promoter) and HSV-1 McKrae were kind gifts from David Leib, while HSV-1
(KOS) was a gift from Peter O’Hare.
Murine ocular HSV-1 infection model. Age matched (6–12-week old) male mice,
were anaesthetized with intraperitoneal (i.p.) injection of ketamine (100mg kg 1
body weight) and xylazine (10mg kg 1 body weight). Corneas were scariﬁed in a
10 10 crosshatch pattern and mice were either inoculated with 1 106 PFU
HSV-1 in 5 ml of infection medium (DMEM containing 200 IUml 1 penicillin and
200mgml 1 streptomycin), or mock infected with 5 ml of infection medium. Mice
were scored for disease and weighed at the indicated times post infection. The
scoring was performed as blinded study, largely following previous descriptions by
others20 with the following minor modiﬁcations: hair loss (0: none, 1: minimal
periocular hair loss, 2: moderate periocular hair loss, 3: severe hair loss limited to
periocular, 4: hair loss severe and extensive); hydrocephalus (0: none, 1: minor
bump, 2: moderate bump, 3: large bump); symptoms related to neurological disease
(0: normal, 1: jumpy, 2: uncoordinated, 3: hunched/lethargic, 4: unresponsive/no
movement); eye swell/lesions (0: none, 1: minor swelling, 2: moderate swelling, 3:
severe swelling and skin lesions, 4: lesions extensive). Mice were killed at the
speciﬁed times post infection or once they met end point criteria. Eye wash was
collected by gently proptosing each eye and wiping a sterile cotton swab three times
around the eye in a circular motion and twice across the center of the cornea. The
swabs were placed in 0.5ml of DMEM medium and stored at  80 C until the
titre was determined.
Brains, brain stems and trigeminal ganglia were frozen immediately at  80 C.
Tissues were homogenized with steel beads (Qiagen) in Tissuelyser (II) (Qiagen)
for 3min at frequency (30 s). One half was used for RNA isolation with TRIzol and
the other half was used for virus plaque assay as described11.
Preparation and culture of organotypic brain slices. Organotypic brain slice
cultures were prepared and grown by the interface culture method as also
previously described35,36. In brief, postnatal day 0–1 mice were quickly decapitated
and the brains isolated under aseptic conditions. After removal of the meninges
and isolation of the brain stem (midbrain and pons, excluding medulla oblongata),
tissue blocks were sectioned transversely at 400mm using a McIlwain tissue
chopper (Mickle Laboratory). The slices were immediately transferred to chilled
Gey’s balanced salt solution (Gibco) supplemented with 30mmol l 1 glucose and
30mmol l 1 KCl (Merck) for subsequent separation and trimming of the slices.
Three tissue slices from the same brain were placed on each semiporous membrane
insert (pore size 0.4 mm; Millipore, Bedford, MA, USA) and transferred to six-well
culture trays with 1ml serum-containing culture medium per well. The medium
was composed of 25% heat-inactivated horse serum (Gibco), 25% Hanks balanced
salt solution (Gibco), 25mmol l 1 D-glucose (Merck) in OPTI-MEM (Gibco). The
organotypic brain slice cultures were grown at 36 C in 5% CO2 for 48 h before
HSV-1 infection (Mckrae; 5 103PFU in 3,5ml per brain slice). Two days post
infection culture medium and six days post infection, brain slices were collected,
homogenized and the viral loads determined as described above.
Isolation and culturing of primary cells. Neurons were isolated from P 0–3 mice
using the Neural Tissue Dissociation Kit (MACS, Miltenyi Biotec) according to the
manufacturer’s instructions. The cells were pre-plated for 45min in culture ﬂasks
to avoid the quickly attaching non-neuronal cells. The ﬂoating neurons were
seeded on poly-D-lysine (Sigma-Aldrich) and laminin (Invitrogen) pre-coated 24-
well plates. The cells were cultured in Neurobasal-A medium (Gibco) containing
B-27 Supplement (Gibco), 2mM GlutaMAX (Gibco), 100 mgml 1 Primocin
(Invivogen) and 20mM ﬂoxuridineþ 20mM uridine (Sigma), and media was
changed every second day. On day 7, purity of the cells was checked by ﬂow
cytometry and the neurons were infected with indicated MOI of HSV-1 and
washed 1 h following infection. For RNA analysis, the few microglia present in the
culture was removed by ﬂuorescence-activated cell sorting (FACS) 500 CD45
cells in to each well on a 96-well plate and analysed on BioMarker (Fluidigm) or by
regular quantitative PCR (qPCR).
The astrocytes and the mixed glial cells were isolated and cultured as previously
described11. In brief, for isolation of glial cells from mice, neonatal cerebra were
collected, trypsinized for 25min and ﬁltered through a 70-mm pore size ﬁlter. Cells of
one cerebrum were then seeded on 1 uncoated 75 cm2 culture ﬂask and incubated
with 40ml DMEM containing 10% FCS. The medium was replenished on days 1 and
4 after plating. Henceforth, either microglia or astrocytes were isolated:
Astrocytes were isolated using the following method: glial cells were passaged
two to three times and shaken at 250 r.p.m. for 48 h, supernatant was aspirated and
the remaining adherent cells were predominantly astrocytes.
The microglia was isolated as described elsewhere37. Shortly, the conﬂuent
mixed glial cultures were grown in DMEM-F12 (Lonza) with FBS for 3–4 weeks,
and the astrocyte layer growing above the microglia were removed using
mild trypsinization (0.05–0.12%) in the presence of 0.2–0.5mM EDTA and
0.5–0.8mM Ca2þ . The remaining adherent microglia cells were isolated by
trypsinization and seeded for the assay.
The purity of the primary cells was in the range 89–97% depending on the cell
type (Supplementary Fig. 4). When using supernatants from microglia cultures to
treat other cell types, the supernatants were ﬁrst ultraviolet-inactivated for 6min.
Immunohistochemistry. Immunohistochemistry was performed as described
previously11. Brieﬂy, the mice were perfused with 4% formaldehyde ﬁxative
through the circulatory system, and postﬁxed with phosphate-buffered 4%
formaldehyde and brain sections were cut at 60-mm thickness and every sixth
section was stained. The antibody retrieval was performed at 80 C for 20min with
Target Retrieval Solution (Dako). The sections were treated with methanolic H2O2
(3% H2O2 and 1% absolute methanol) for 30min to inactivate endogenous
peroxidase activity. The sections were then blocked with 0.5% bovine serum
albumin (BSA) in TBS for 1 h at room temperature (RT), and incubated overnight
at 4 C with rabbit polyclonal anti-HSV-1 (1:500; DakoCytomation, B0116)
antibody in tris-buffered saline (TBS) containing 0.1% BSA, 0.3% Triton-X,
followed by several washes in TBS containing 0.3% Triton-X TBS and staining with
and the secondary antibody, donkey anti-rabbit HRP (1:500; Sigma-Aldrich) for 1 h
at RT. Horseradish peroxidase-labelled antibodies were developed with chromagen
diaminobenzidine. Finally, the slides were rinsed in water, dehydrated and
prepared for imaging. The imaging was performed on Zeiss AX10, Scope A1
microscope using  20 and  2.5 objectives.
Confocal microscopy of tissue sections and glia cell cultures. For astrocyte,
microglia, neuronal and viperin staining, 50-mm cryosections (HM 500 OM,
Mikrom) were stained and imaged as described above and previously11. The
sections were incubated in TEG buffer (10mM Tris Base, 0.5mM EGTA, pH 9) at
60 C overnight and subsequently treated with methanolic H2O2 (3% H2O2 and 1%
absolute methanol) for 30min. The sections were washed and incubated with
primary antibodies at 4 C overnight, including mouse monoclonal anti-NeuN
(1:300; clone A60, Millipore), mouse monoclonal anti-GFAP (1:400; clone G-A-5,
Sigma-Aldrich), mouse monoclonal anti-S100 (1:200; Clone 4C4.9, Abcam), mouse
monoclonal anti-viperin (1:400; clone MaP.VIP, Milipore), rabbit polyclonal
anti-HSV-1 (1:500; DakoCytomation, B0116) and goat polyclonal anti-Iba1 (1:400;
Abcam; ab5076). As a control for staining, we used secondary antibody alone and
isotype control in case the primary antibody was monoclonal. After several washes
in TBS containing 0.3% Triton-X TBS, the secondary antibodies (all at dilution
1:500; Invitrogen; chicken anti-mouse Alexa Fluor 647, donkey anti-rabbit Alexa
Fluor 568, chicken anti-goat Alexa Fluor 488) were incubated for 1 h at 20 C.
Nuclei were stained with 4,6-diamidino-2-phenylindole for 6min. The sections
were washed ﬁve times in 0.3% Triton-X in TBS and mounted using ProLong Gold.
Sections were imaged on a Zeiss LSM 710 laser scanning microscope. Zen 2010
acquisition software and ImageJ (http://rsbweb.nih.gov/ij/) were used for imaging
and analysis. For microscopy on cells cultured in vitro, isolated microglia and
astrocytes were mixed 1:1 and grown together on glass cover slips for 48 h and
infected with HSV-1 (KOS, MOI 10) for 4 h. The cells were ﬁxed and stained as
described11. The antibodies used were mouse anti-GFAP (1:400; Sigma-Aldrich;
GA5), Rabbit anti-STING (1:100; IMGENEX, IMG-6485A); and secondary
antibodies (1:300), Alexa Fluor 488 Donkey anti-mouse IgG (A21202) and Alexa
Fluor 568 Donkey anti-rabbit IgG(A10042) from Life Technologies.
RNA isolation and quantitative RT–PCR. The RNA puriﬁcation and qPCR
was preformed as described11, with the following primers from Applied
Biosystems: TLR3 (Mm01207404_m1), cGAS (Mm01147497_m1), STING
(Mm01158117_m1), MX1 (Mm00487796_m1), ISG15 (Mm01705338_s1), Viperin
(Mm00491265_m1), IL-6 (Mm00446190_m1), IFN-b (Mm00439552_s1), CXCL10
(Mm00445235_m1), HSV-1 gB (the forward primer (50-CGC ATC AAG ACC A
CC TCC TC-30), the reverse primer (50-AGC TTG CGG GCC TCG TT-30) and
probe: 50-CGG CCC AAC ATA TCG TTG ACA TGG C-30), Iba-1 (Mm00479862_
g1) and HSV-1 LAT (The forward primer (50-ACCCACGTACTCCAAGAAGG
C-30), the reverse primer (50-TAAGACCCAAGCATAGAGAGCCA-30 and probe
(50-TCCCACCCCGCCTGTGTTTTTGT-30)). Levels of mRNAs of interest were
normalized to b-actin using the formula 2Ct(bactin)Ct(mRNA X). The resulting
normalized ratio were either presented directly in the ﬁgures or further normalized
to the normalized ratio of untreated WT cells as speciﬁed in the ﬁgure legends.
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Fluidigm. Complementary DNA (cDNA) was isolated from 500 FACS-sorted cells
and speciﬁc targets were pre-ampliﬁed in one step by using the CellDirect
One-Step qRT-PCR kit (Invitrogen) according to the manufacturer’s instructions.
Brieﬂy, 500 FACS-sorted cells were combined with SUPERase-In (Ambion),
SuperScript II RT/Platinum Taq mix (Invitrogen) and 0.2 of all primers used in
the present study (TaqMan gene expression assays, Applied Biosystems). The PCR
with reverse transcription (RT–PCR) was performed using the thermal cycling
protocol: RT (incubated 50 C for 15min),Taq activation (95 C for 2min), fol-
lowed by 15 cycles of (95 C at 15 s and 60 C at 4min). Pre-ampliﬁed cDNA was
diluted at least 1:5 in low EDTA TE-buffer (VWR—Bie & Berntsen) before real-
time qPCR on the BioMarker (Fluidigm). qPCR was performed in the 48.48
Dynamic Array Integrated Fluidic Circuits (Fluidigm) combining 48 pre-ampliﬁed
samples with some of the primers as mentioned above. The following reagents were
used for 48 reactions of pre-sample mix: 3 ml of TaqMan gene expression master
mix (Applied Biosystems), 0.3 ml of 20 GE sample loading reagent (Fluidigm),
6 ml low EDTA TE buffer (VWR—Bie & Berntsen) and 2.7 ml diluted pre ampliﬁed
cDNA. Primer mixes were prepared using 2.5 ml of 20 TaqMan gene expression
assays (Applied Biosystems) as described above and 2.5 ml of 2 assay loading
reagent (Fluidigm). The 48.48 Dynamic Array was primed in the IFC controller
(Fluidigm) before loading of sample and primer. Sample mix, including cDNA
(5ml) and primer mix (5 ml) was dispensed into appropriate inlets and loaded into
the chip in the IFC controller, combining each sample with each primer pair in
separate reactions. The plate was placed in the BioMark PCR instrument
(Fluidigm) and the standard protocol was followed. Data was acquired using the
Fluidigm Real-Time PCR Analysis software 3.0.2 (Fluidigm).
Enzyme-linked immunosorbent assay and type I IFN bioassay. Supernatants
from primary CNS cells were inactivated by irradiation with ultraviolet light for
measurement of type I IFN bioassay or CXCL10 by enzyme-linked immunosorbent
assay as described previously38.
Western blotting. Eye and brain tissues were lysed and used for western blotting
as described previously38. Brieﬂy, the tissues were lysed in RIPA buffer in the
presence of protease and phosphatase inhibitors then subjected to homogenization
and centrifugation. The cleared supernatants were sonicated, and samples were
subjected to SDS–polyacrylamide gel electrophoresis and immunoblotting. The
blots were blocked with 2.5% BSA and probed with the following primary
antibodies: polyclonal sheep anti-STING (1:100; R&D, AF-6516) and mouse
monoclonal anti-Vinculin (1:1,000; Sigma, clone hVIN-1,V9131). Appropriate
peroxidase-conjugated secondary antibodies were used for development (Jackson
ImmunoResearch). Secondary antibodies were as follows: anti-goat, catalogue no.
705-306-147; anti-rabbit, catalogue no. 711-035-152; and anti-mouse, catalogue no.
715-036-150 (all used at dilution 1:10,000).
FACS sorting and ﬂow cytometry. The stimulated neurons were stained for
CD45, and 500 CD45 cells were FACS sorted into a 96-well plate and used for
mRNA quantiﬁcation either by Fluidigm or by regular qPCR as described above. In
the assays with GFP-HSV-1-infected neurons, the CD45 cells were further
divided into GFP and GFPþ populations before RNA analyses. Similarly, in
GFP-HSV-1-infected mixed culture of astrocytes and microglia, both CD45þ and
CD45 cells were divided in to GFPþ and GFP population of 500 cells. For
CD45 staining, cells were ﬁrst blocked for 15min with mouse IgG (Jackson
ImmunoResearch Inc.) and puriﬁed rat anti-mouse CD16/CD32 (Mouse BD Fc
Block) to prevent non-speciﬁc binding. The antibodies rat anti-CD45-APC (Clone
30-F11,BD, Pharmingen) and APC Rat IgG2b, k isotype control (BD, Pharmingen)
were added and incubated in (1:200) for 15min at 20 C in the dark. After washing
with PBS/BSA (PBS, pH 7.4, supplemented with 0.5% BSA) the cells were analysed
or sorted on a FC500 ﬂow cytometer (Beckman Coulter) or a FACSAria III (BD
Biosciences). Subsequently, FlowJo software version 8.8.3 (Tree Star Inc.) was used
for data analysis. For quantifying primary cells, the cells were trypsinized, ﬁxed in
methanol, permeabilized in 0.5% Triton X-100, and the blocking and antibody
staining and analysis were done as described above for CD45 staining. The anti-
bodies used were mouse anti-GFAP-PE (1:200; Clone GA5, Millipore) and isotype
control IgG1K-PE (Millipore). The staining for neurons was done similarly, where
blocking was done in 10% BSA and the antibody used was mouse monoclonal anti-
NeuN (1:300; clone A60, Millipore), together with the secondary antibody chicken
anti-mouse Alexa 647 (1:500), or the secondary antibody alone. For quantifying
microglia from adult mouse brains, the brain stems were made into single-cell
suspension by carefully triturating with Pasteur glass pipettes (VWR) with
decreasing diameter until it became a homogenous cell suspension. Large debris
and cell clusters were removed by ﬁltration through a 70-mm cell strainer (BD
Biosciences #352350) and myelin debris was reduced by three-density step gradient
of Percol (Sigma) as described39. The cells were then washed and stained as
described above with anti-CD45-APC and rat monoclonalanti-CD11b-BV421
1:300 (clone M1/70, Biolegend) and their isotype controls (APC Rat IgG2b, k) and
(BV421 Rat IgG2b, k). The microglia were also stained with mouse monoclonal
anti-Iba-1-FITC (1:100; Clone 1022-5, Abcam) or isotype control mouse
IgG2b–FITC(Abcam). The gating strategies used for the ﬂow cytometry
experiments are shown in Supplementary ﬁg. 11.
Statistics. For statistical analysis of data on cytokines, chemokines and virus titres,
we used two-tailed Student’s t-test when the data exhibited normal distribution,
and Wilcoxon rank-sum test when the data set did not pass the normal distribution
test. Pr0.05 were considered to reﬂect statistically signiﬁcant differences between
compared groups. Symbols for P-values used in the ﬁgures: *0.01oPo0.05,
**0.001oPo0.01, ***Po0.001. The data shown are representative of one out of
three or more experiments and all samples in a group are biological replicates.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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